Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascade

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region

N. Kudo, Nobuaki Matsumori, Hiroshi Taoka et al. · Proceedings of the National Academy of Sciences · 1999 · 1K citations

Life Sciences, Biochemistry, Molecular Biology +13

Leptomycin B Inhibition of Signal-Mediated Nuclear Export by Direct Binding to CRM1

N. Kudo, Barbara Wolff, Toshihiro Sekimoto et al. · Experimental Cell Research · 1998 · 824 citations

Life Sciences, Cell Biology, Molecular Biology +11

Genomic and molecular characterization of esophageal squamous cell carcinoma

De‐Chen Lin, Jia‐Jie Hao, Yasunobu Nagata et al. · Nature Genetics · 2014 · 662 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Liwei Cao, Chen Huang, Daniel Cui Zhou et al. · Cell · 2021 · 599 citations · Full text

Medicine, Cancer Biology, Oncology +15